Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis
- 1 September 1997
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 42 (3), 372-375
- https://doi.org/10.1002/ana.410420316
Abstract
Activated protein C resistance caused by an Arg506Gln mutation in the factor V gene (factor V Leiden mutation) is the most common cause of familial thrombosis. This mutation is associated with arterial and venous thromboembolic disease in neonates, infants, and children, but is not a significant risk factor for ischemic stroke in adults. We report on 3 babies with different neonatal cerebrovascular disorders including ischemic infarction and hemorrhagic stroke who are heterozygous for factor V Leiden mutation. One infant had multiple thrombi in the fetal placental vasculature. This is the first reported association between hemiplegic cerebral palsy, placental thrombosis, and factor V Leiden mutation. We suspect that activated protein C resistance may be an important cause of in utero cerebrovascular disease and hemiplegic cerebral palsy.Keywords
This publication has 22 references indexed in Scilit:
- Thrombosis in otherwise well children with the factor V Leiden mutationThe Journal of Pediatrics, 1996
- Ischemic Stroke in the ElderlyStroke, 1996
- Arg506–Gln mutation in factor V and risk of thrombosis during pregnancyBritish Journal of Haematology, 1996
- Ischemic Stroke in Young Patients With Activated Protein C ResistanceStroke, 1995
- Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.Journal of Clinical Investigation, 1994
- Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism.Journal of Clinical Investigation, 1994
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjectsBlood Coagulation & Fibrinolysis, 1994
- Neonatal Purpura Fulminans Due to Homozygous Protein C or Protein S DeficienciesSeminars in Thrombosis and Hemostasis, 1990